Central pathology review for phase III clinical trials

The enabling effect of virtual microscopy

Pawel Mroz, Anil V. Parwani, Piotr Kulesza

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Context. - Central pathology review (CPR) was initially designed as a quality control measure. The potential of CPR in clinical trials was recognized as early as in the 1960s and quickly became embedded as an integral part of many clinical trials since. Objective. - To review the current experience with CPR in clinical trials, to summarize current developments in virtual microscopy, and to discuss the potential advantages and disadvantages of this technology in the context of CPR. Data Sources. - A PubMed (US National Library of Medicine) search for published studies was conducted, and the relevant articles were reviewed, accompanied by the authors' experience at their practicing institution. Conclusions. - The review of the available literature strongly suggests the growing importance of CPR both in the clinical trial setting as well as in second opinion cases. However, the currently applied approach significantly impedes efficient transfer of slides and patient data. Recent advances in imaging, digital microscopy, and Internet technologies suggest that the CPR process may be dramatically streamlined in the foreseeable future to allow for better diagnosis and quality assurance than ever before. In particular, whole slide imaging may play an important role in this process and result in a substantial reduction of the overall turnaround time required for slide review at the central location. Above all, this new approach may benefit the large clinical trials organized by oncology cooperative groups, since most of those trials involve complicated logistics owing to enrollment of large number of patients at several remotely located participating institutions.

Original languageEnglish (US)
Pages (from-to)492-495
Number of pages4
JournalArchives of Pathology and Laboratory Medicine
Volume137
Issue number4
DOIs
StatePublished - Apr 1 2013

Fingerprint

Phase III Clinical Trials
Microscopy
Pathology
Clinical Trials
National Library of Medicine (U.S.)
Technology
Patient Transfer
Information Storage and Retrieval
PubMed
Quality Control
Internet
Referral and Consultation

Cite this

Central pathology review for phase III clinical trials : The enabling effect of virtual microscopy. / Mroz, Pawel; Parwani, Anil V.; Kulesza, Piotr.

In: Archives of Pathology and Laboratory Medicine, Vol. 137, No. 4, 01.04.2013, p. 492-495.

Research output: Contribution to journalReview article

@article{566662eee9134790a0948c4849342a82,
title = "Central pathology review for phase III clinical trials: The enabling effect of virtual microscopy",
abstract = "Context. - Central pathology review (CPR) was initially designed as a quality control measure. The potential of CPR in clinical trials was recognized as early as in the 1960s and quickly became embedded as an integral part of many clinical trials since. Objective. - To review the current experience with CPR in clinical trials, to summarize current developments in virtual microscopy, and to discuss the potential advantages and disadvantages of this technology in the context of CPR. Data Sources. - A PubMed (US National Library of Medicine) search for published studies was conducted, and the relevant articles were reviewed, accompanied by the authors' experience at their practicing institution. Conclusions. - The review of the available literature strongly suggests the growing importance of CPR both in the clinical trial setting as well as in second opinion cases. However, the currently applied approach significantly impedes efficient transfer of slides and patient data. Recent advances in imaging, digital microscopy, and Internet technologies suggest that the CPR process may be dramatically streamlined in the foreseeable future to allow for better diagnosis and quality assurance than ever before. In particular, whole slide imaging may play an important role in this process and result in a substantial reduction of the overall turnaround time required for slide review at the central location. Above all, this new approach may benefit the large clinical trials organized by oncology cooperative groups, since most of those trials involve complicated logistics owing to enrollment of large number of patients at several remotely located participating institutions.",
author = "Pawel Mroz and Parwani, {Anil V.} and Piotr Kulesza",
year = "2013",
month = "4",
day = "1",
doi = "10.5858/arpa.2012-0093-RA",
language = "English (US)",
volume = "137",
pages = "492--495",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "4",

}

TY - JOUR

T1 - Central pathology review for phase III clinical trials

T2 - The enabling effect of virtual microscopy

AU - Mroz, Pawel

AU - Parwani, Anil V.

AU - Kulesza, Piotr

PY - 2013/4/1

Y1 - 2013/4/1

N2 - Context. - Central pathology review (CPR) was initially designed as a quality control measure. The potential of CPR in clinical trials was recognized as early as in the 1960s and quickly became embedded as an integral part of many clinical trials since. Objective. - To review the current experience with CPR in clinical trials, to summarize current developments in virtual microscopy, and to discuss the potential advantages and disadvantages of this technology in the context of CPR. Data Sources. - A PubMed (US National Library of Medicine) search for published studies was conducted, and the relevant articles were reviewed, accompanied by the authors' experience at their practicing institution. Conclusions. - The review of the available literature strongly suggests the growing importance of CPR both in the clinical trial setting as well as in second opinion cases. However, the currently applied approach significantly impedes efficient transfer of slides and patient data. Recent advances in imaging, digital microscopy, and Internet technologies suggest that the CPR process may be dramatically streamlined in the foreseeable future to allow for better diagnosis and quality assurance than ever before. In particular, whole slide imaging may play an important role in this process and result in a substantial reduction of the overall turnaround time required for slide review at the central location. Above all, this new approach may benefit the large clinical trials organized by oncology cooperative groups, since most of those trials involve complicated logistics owing to enrollment of large number of patients at several remotely located participating institutions.

AB - Context. - Central pathology review (CPR) was initially designed as a quality control measure. The potential of CPR in clinical trials was recognized as early as in the 1960s and quickly became embedded as an integral part of many clinical trials since. Objective. - To review the current experience with CPR in clinical trials, to summarize current developments in virtual microscopy, and to discuss the potential advantages and disadvantages of this technology in the context of CPR. Data Sources. - A PubMed (US National Library of Medicine) search for published studies was conducted, and the relevant articles were reviewed, accompanied by the authors' experience at their practicing institution. Conclusions. - The review of the available literature strongly suggests the growing importance of CPR both in the clinical trial setting as well as in second opinion cases. However, the currently applied approach significantly impedes efficient transfer of slides and patient data. Recent advances in imaging, digital microscopy, and Internet technologies suggest that the CPR process may be dramatically streamlined in the foreseeable future to allow for better diagnosis and quality assurance than ever before. In particular, whole slide imaging may play an important role in this process and result in a substantial reduction of the overall turnaround time required for slide review at the central location. Above all, this new approach may benefit the large clinical trials organized by oncology cooperative groups, since most of those trials involve complicated logistics owing to enrollment of large number of patients at several remotely located participating institutions.

UR - http://www.scopus.com/inward/record.url?scp=84876576674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876576674&partnerID=8YFLogxK

U2 - 10.5858/arpa.2012-0093-RA

DO - 10.5858/arpa.2012-0093-RA

M3 - Review article

VL - 137

SP - 492

EP - 495

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 4

ER -